Oncoclínicas do Brasil Serviços Médicos S.A.

B3:ONCO3.SA

5.59 (BRL) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) BRL.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 1,567.631,458.6661,434.2461,401.5481,359.5231,293.4591,216.5281,163.872899.9807.952767.879679.42640.215614.552574.319524.858482.655453.359
Cost of Revenue 1,040.662976.386947.481905.766884.039822.914764.437756.473578.614536.621502.267460.52450.706419.782385.881356.661330.86326.112
Gross Profit 526.968482.28486.765495.782475.484470.545452.091407.399321.286271.331265.612218.9189.509194.77188.438168.197151.795127.247
Gross Profit Ratio 0.3360.3310.3390.3540.350.3640.3720.350.3570.3360.3460.3220.2960.3170.3280.320.3150.281
Reseach & Development Expenses 000.03700.0020.039000000000000
General & Administrative Expenses 311.121316.967303.865308.746288.221271.237255.198277.121248.094200.404194.53218.408335.529139.581248.869112.286118.267115.673
Selling & Marketing Expenses 000000000000000000
SG&A 311.121316.967303.865308.746288.221271.237255.198277.121248.094200.404194.53218.408335.529139.581248.869112.286118.267115.673
Other Expenses 000000000000000000
Operating Expenses 311.121316.967303.865312.327288.089264.479260.65276.291245.308198.76192.49422.538337.166139.378255.005113.114131.286121.65
Operating Income 215.847165.313182.9184.264187.606195.2131,190.922-276.29175.978106.011676.297-22.538-147.65755.392380.672-113.11434.0175.597
Operating Income Ratio 0.1380.1130.1280.1310.1380.1510.979-0.2370.0840.1310.881-0.033-0.2310.090.663-0.2160.070.012
Total Other Income Expenses Net -175.022-190.415-59.398-146.319-117.117-120.271-1,125.794311.183-70.469-90-625.686190.311-36.133-27.65-479.401153.248-23.646-14.491
Income Before Tax 40.825-25.102123.50237.94570.48974.94265.12834.8925.50916.01150.611167.773-183.7927.742-98.72940.13410.371-8.894
Income Before Tax Ratio 0.026-0.0170.0860.0270.0520.0580.0540.030.0060.020.0660.247-0.2870.045-0.1720.0760.021-0.02
Income Tax Expense 16.797-44.69232.104-111.38735.51933.72-31.816-22.15330.10231.63627.88216.98518.73821.14924.78717.7814.02211.498
Net Income 3.3029.59275.439104.98921.00622.18471.11430.833-32.694-22.99315.292145.177-204.888-2.481-142.61414.069-9.327-21.747
Net Income Ratio 0.0020.0070.0530.0750.0150.0170.0580.026-0.036-0.0280.020.214-0.32-0.004-0.2480.027-0.019-0.048
EPS 0.0060.0180.150.20.0410.0430.150.065-0.063-0.0480.0320.31-0.51-0.006-0.360.035-0.023-0.054
EPS Diluted 0.0060.0170.140.20.040.0430.140.065-0.062-0.0480.0320.31-0.51-0.006-0.360.035-0.023-0.054
EBITDA 285.58232.962248.774252.796249.011255.463224.404187.664154.754140.991133.365241.664-113.15884.008-36.02262.88749.31127.507
EBITDA Ratio 0.1820.160.1730.180.1830.1980.1840.1610.1720.1750.1740.356-0.1770.137-0.0630.120.1020.061